Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 14/20 | 0.48 |
| ▸ | FNTB | P49356 | 14/20 | 0.48 |
| ▸ | PGGT1B | P53609 | 13/20 | 0.48 |
| ▸ | NPY4R | P50391 | 4/20 | 0.42 |
| ▸ | NPY1R | P25929 | 3/20 | 0.42 |
| ▸ | NPY2R | P49146 | 2/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630489 | 0.95 | FNTA (0.45) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL29592000 | 0.94 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL2543473 | 0.93 | FNTA (0.54) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL15011155 | 0.93 | FNTA (0.54) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL9189133 | 0.93 | FNTA (0.54) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL31157679 | 0.92 | FNTA (0.46) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL31122838 | 0.90 | FNTA (0.49) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30512030 | 0.90 | NPY4R (0.43) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30479333 | 0.90 | FNTA (0.51) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL29452026 | 0.90 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |